Elevated Systemic Immune-inflammatory Index Predicts Poor Coronary Collateralization in Type 2 Diabetic Patients with Chronic Total Occlusion

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Dec 30

PMID 39735863

Authors

Lin Shuang Mao

Yi Xuan Wang

Zhi Ming Wu

Feng Hua Ding

Lin Lu

Wei Feng Shen

Yang Dai

Ying Shen

Affiliations

Soon will be listed here.

Abstract

Objective: This study compared the value of different systemic immune-inflammatory markers for evaluating coronary collateralization (CC) in patients with type 2 diabetes mellitus (T2DM) and chronic total occlusion (CTO).

Methods: Systemic immune-inflammation index (SII), systemic inﬂammation response index (SIRI) and pan-immune-inﬂammation value (PIV) were calculated at admission in 1409 T2DM patients with CTO. The degree of coronary collaterals was estimated using the Rentrop scoring system and categorized into poor (Rentrop score 0 or 1) or good (Rentrop score 2 or 3) CC. The predictors of poor CC were determined by multivariate regression analysis, and the diagnostic potential of these indexes was analyzed by Receiver Operating Characteristic (ROC) curves.

Results: SII, SIRI and PIV levels increased stepwise across Rentrop score 0-3, with significantly higher levels in patients with poor CC than in those with good CC ( < 0.001). After adjusting for confounders, SII, SIRI and PIV (per tertile) remained independent factors for poor CC. SII predicted poor CC better than SIRI and PIV (AUC: 0.758 vs. 0.680 and 0.698, all < 0.001). There existed an interaction between blood concentration of HbA1c and SII ( < 0.001), with high SII levels being associated with a greater risk (OR: 5.058 vs. 2.444) and providing a better predictive ability for poor CC (AUC: 0.817 vs. 0.731) in patients with HbA1c < 6.5% compared to those with HbA1c ≥ 6.5%.

Conclusion: Our study shows that elevated SII provides a better prediction for poor CC in T2DM patients with CTO especially at good glycemic control.

References

Akdag S, Akyol A, Asker M, Ozturk F, Ali Gumrukcuoglu H . The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with non-ST segment elevation myocardial infarction. Postepy Kardiol Interwencyjnej. 2016; 12(3):224-30. PMC: 5011538. DOI: 10.5114/aic.2016.61644. View

Yetkin E, Topal E, Erguzel N, Senen K, Heper G, Waltenberger J . Diabetes mellitus and female gender are the strongest predictors of poor collateral vessel development in patients with severe coronary artery stenosis. Angiogenesis. 2015; 18(2):201-7. DOI: 10.1007/s10456-015-9460-y. View

Allahwala U, Khachigian L, Nour D, Ridiandres A, Billah M, Ward M . Recruitment and maturation of the coronary collateral circulation: Current understanding and perspectives in arteriogenesis. Microvasc Res. 2020; 132:104058. DOI: 10.1016/j.mvr.2020.104058. View

Bugra Nacar A, Erayman A, Kurt M, Buyukkaya E, Karakas M, Akcay A . The relationship between coronary collateral circulation and neutrophil/lymphocyte ratio in patients with coronary chronic total occlusion. Med Princ Pract. 2014; 24(1):65-9. PMC: 5588179. DOI: 10.1159/000365734. View

Yilmaz Y, Kelesoglu S . The Importance of Pan-Immune Inflammation Value (PIV) in Predicting Coronary Collateral Circulation in Stable Coronary Artery Patients. Angiology. 2024; :33197241258529. DOI: 10.1177/00033197241258529. View

Xiang J, He L, Li D, Wei S, Wu Z . Value of the systemic immune-inflammation index in predicting poor postoperative outcomes and the short-term prognosis of heart valve diseases: a retrospective cohort study. BMJ Open. 2022; 12(10):e064171. PMC: 9557268. DOI: 10.1136/bmjopen-2022-064171. View

Liu Y, Liu J, Liu L, Cao S, Jin T, Chen L . Association of Systemic Inflammatory Response Index and Pan-Immune-Inflammation-Value with Long-Term Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention. J Inflamm Res. 2023; 16:3437-3454. PMC: 10438435. DOI: 10.2147/JIR.S421491. View

Yang Y, Wu C, Hsu P, Chen S, Huang S, Leong Chan W . Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020; 50(5):e13230. DOI: 10.1111/eci.13230. View

Margraf A, Lowell C, Zarbock A . Neutrophils in acute inflammation: current concepts and translational implications. Blood. 2021; 139(14):2130-2144. PMC: 9728535. DOI: 10.1182/blood.2021012295. View

10.

Rentrop K, Cohen M, Blanke H, Phillips R . Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985; 5(3):587-92. DOI: 10.1016/s0735-1097(85)80380-6. View

11.

Uysal O, Turkoglu C, Sahin D, Duran M, Yildirim A, Elbasan Z . The relationship between neutrophil-to-lymphocyte ratio and coronary collateral circulation. Clin Appl Thromb Hemost. 2013; 21(4):329-33. DOI: 10.1177/1076029613503399. View

12.

Waltenberger J . Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res. 2001; 49(3):554-60. DOI: 10.1016/s0008-6363(00)00228-5. View

13.

Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J . Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and Risk of All-Cause Mortality and Cardiovascular Mortality: A 20-Year Follow-Up Cohort Study of 42,875 US Adults. J Clin Med. 2023; 12(3). PMC: 9918056. DOI: 10.3390/jcm12031128. View

14.

Levey A, Eckardt K, Tsukamoto Y, Levin A, Coresh J, Rossert J . Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6):2089-100. DOI: 10.1111/j.1523-1755.2005.00365.x. View

15.

Choi S, Choi B, Rha S, Baek M, Ryu Y, Park Y . Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Chronic Total Coronary Occlusion With Well-Developed Collaterals. J Am Heart Assoc. 2017; 6(9). PMC: 5634287. DOI: 10.1161/JAHA.117.006357. View

16.

Zhou Y, Li W, Xia S, Xiang T, Tang C, Luo J . Predictive Value of the Systemic Immune Inflammation Index for Adverse Outcomes in Patients With Acute Ischemic Stroke. Front Neurol. 2022; 13:836595. PMC: 8971364. DOI: 10.3389/fneur.2022.836595. View

17.

Bao X, Dai Y, Lu L, Wang X, Ding F, Shen W . Vasostatin-2 associates with coronary collateral vessel formation in diabetic patients and promotes angiogenesis via angiotensin-converting enzyme 2. Eur Heart J. 2023; 44(19):1732-1744. DOI: 10.1093/eurheartj/ehad082. View

18.

Pec J, Buchner S, Wester M, Debl K, Hamer O, Poschenrieder F . Association of Coronary Collaterals and Myocardial Salvage Measured by Serial Cardiac Magnetic Resonance Imaging after Acute Myocardial Infarction. J Cardiovasc Dev Dis. 2023; 10(12). PMC: 10743778. DOI: 10.3390/jcdd10120473. View

19.

Khan M, Wendel C, Thai H, Movahed M . Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: a meta-analysis comparing successful versus failed percutaneous intervention for chronic total occlusion. Catheter Cardiovasc Interv. 2013; 82(1):95-107. DOI: 10.1002/ccd.24863. View

20.

Seiler C, Stoller M, Pitt B, Meier P . The human coronary collateral circulation: development and clinical importance. Eur Heart J. 2013; 34(34):2674-82. DOI: 10.1093/eurheartj/eht195. View